Unraveling the pathogenetic overlap of Helicobacter pylori and metabolic syndrome-related Porphyromonas gingivalis: Gingipains at the crossroads and as common denominator
Microbiological Research · 2025-10 · 299 · 128255
DOI: 10.1016/j.micres.2025.128255 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbiological Research, 2025-10. Verfasst von Michael Doulberis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Department of Medicine, Zurich University Hospital, Zurich 8091, Switzerland; Division of Gastroentero…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Helicobacter pylori, Porphyromonas gingivalis, Gingipain Cysteine Endopeptidases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 170 Literaturangaben.
Abstract (Originalsprache)
Chronic bacterial infections exert profound systemic effects beyond their primary infection sites, influencing a range of inflammatory, metabolic, and neurodegenerative diseases. Helicobacter pylori (Hp) and Porphyromonas gingivalis (Pg) are two highly prevalent pathogens that, despite occupying distinct niches, share remarkable pathogenic similarities. Both bacteria, connected with metabolic syndrome, employ immune evasion strategies, induce chronic inflammation, and contribute to systemic diseases such as metabolic-associated steatotic liver disease, cardiovascular disease, and neurodegeneration, such as Alzheimer's disease. A key unifying factor in their pathogenicity is the role of gingipains-cysteine proteases produced by Pg-which facilitate bacterial invasion, immune modulation, and tissue destruction. Emerging evidence suggests that Hp possesses analogous proteolytic enzymes, further supporting their potential synergistic impact on host health. Moreover, both pathogens have been implicated in metabolic syndrome-related blood-brain barrier disruption, chronic (smoldering) systemic inflammation, and lipid metabolism dysregulation, contributing to progressive neurodegenerative and cardiovascular disorders. The role of galectins, particularly galectin-3, in modulating microglial activation and inflammatory pathways further highlights their involvement in neuroinflammatory diseases. Targeting gingipains presents a promising therapeutic avenue, with bismuth compounds and novel inhibitors showing potential in disrupting these proteases and mitigating their systemic effects. Understanding the interactions between Hp and metabolic syndrome-related Pg is crucial for developing comprehensive treatment strategies, integrating gastroenterology, periodontology, and neurology. Addressing these infections at both local and systemic levels may improve long-term health outcomes and reduce the burden of chronic inflammatory diseases linked to microbial persistence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Department of Medicine, Zurich University Hospital, Zurich 8091, Switzerland; Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aara…
- Dermatology Department, University of Patras, Patras, Greece.
- Second Medical Clinic, Ippokration Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece; First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thess…
- Second Medical Clinic, Ippokration Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece; Department of Nutritional Sciences and Dietetics, School of Health Sciences, Intern…
- Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Second Medical Clinic, Ippokration Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece. Electronic address: jannis@auth.gr.
Zitieren
APA
Doulberis, M., Tsilimpotis, D., Polyzos, S. A., Vardaka, E., Salahi-Niri, A., Yadegar, A., & Kountouras, J. (2025). Unraveling the pathogenetic overlap of Helicobacter pylori and metabolic syndrome-related Porphyromonas gingivalis: Gingipains at the crossroads and as common denominator. Microbiological Research, 299, 128255. https://doi.org/10.1016/j.micres.2025.128255
Vancouver
Doulberis M, Tsilimpotis D, Polyzos SA, Vardaka E, Salahi-Niri A, Yadegar A, et al. Unraveling the pathogenetic overlap of Helicobacter pylori and metabolic syndrome-related Porphyromonas gingivalis: Gingipains at the crossroads and as common denominator. Microbiological Research. 2025;299:128255. doi:10.1016/j.micres.2025.128255
BibTeX
@article{Doulberis2025,
author = {Doulberis, Michael and Tsilimpotis, Dimitrios and Polyzos, Stergios A and Vardaka, Elisabeth and Salahi-Niri, Aryan and Yadegar, Abbas and Kountouras, Jannis},
title = {Unraveling the pathogenetic overlap of Helicobacter pylori and metabolic syndrome-related Porphyromonas gingivalis: Gingipains at the crossroads and as common denominator},
journal = {Microbiological Research},
year = {2025},
volume = {299},
pages = {128255},
doi = {10.1016/j.micres.2025.128255}
}
EUVIMED